López-Carmona JM, Ariza-Andraca CR, Rodríguez-Moctezuma JR, Munguía-Miranda C

Language: Spanish
References: 27
Page: 259-268
PDF size: 116.40 Kb.

ABSTRACT

Objective. To develop and validate a specific instrument to measure lifestyle of type 2 diabetes mellitus (DM2) patients. Material and Methods. A longitudinal, observational, prospective study was conducted between March 2001 and April 2002 at family medicine healthcare units of the Instituto Mexicano del Seguro Social (Mexican Institute of Social Security (MISS)) in Mexico State’s East District. A self-administered instrument (instrument to measure diabetic lifestyles, IMEVID) was designed to measure the lifestyles of diabetic patients. It was submitted for review by a multidisciplinary group of experts who assessed its logical and content validity to measure the lifestyle in DM2 patients. The instrument was administered on two different days to 412 adult subjects with DM2. Some items were excluded on the basis of the frequency with which their answer choices were selected, as well as the item-total correlation, and the item’s significant loads in several domains in factorial analysis. Results. The sample population consisted of 389 (94.7 % response) subjects who completed the study. Intraclass correlation coefficients for logical and content validity were 0.91 and 0.95 respectively. After depuration of items, the instrument had 25 closed items grouped in 7 domains: nutrition, physical activity, tobacco consumption, alcohol consumption, information on diabetes, emotions, and therapeutic adherence. The global rating of the questionnaire had a Cronbach’s alpha of 0.81 and a test-retest correlation coefficient of 0.84. Conclusions. The specific questionnaire IMEVID is the first to measure the lifestyle in subjects with DM2. It has logical validity, content validity, and a good level of consistency.

REFERENCES

1. Mann JI. The role of nutritional modifications in the prevention of macrovascular complications of diabetes. Diabetes 1997;46 (Suppl 2): S125-S130.

2. American Diabetes Association. Nutrition recommendations and principles for people with diabetes mellitus. Diabetes Care 1998; 21(Suppl 1):S32-S35.

3. American Diabetes Association. Diabetes mellitus and exercise. Diabetes Care 1998;21(Suppl 1):S40-S44.

4. Bloomgarden ZT. Obesity and diabetes. Diabetes Care 2000;23: 1584-1590.

5. Wei M, Kampert JB, Gibbons LW, Blair SN, Mitchell TL. Alcohol intake and incidence of type 2 diabetes in men. Diabetes Care 2000;23:18-22.

6. Haire JD, Glasgow RE, Tibbs TL. Smoking and diabetes. Diabetes Care 1999;22(11):1887-1898.

7. Usitupa MI. Early lifestyle intervention in patients with non-insulin dependent diabetes mellitus and impaired glucose tolerance. Ann Med 1996;28:445-449.

8. Franz MJ. Lifestyle modifications for diabetes management. Endocrinol Metab Clin North Am 1997;26(3):499-510.

9. World Health Organization. Lifestyles and health. Soc Sci Med 1986;22(2):117-124.

10. Wilson DM, Ciliska D. Lifestyle assessment: Development and use of the FANTASTIC Checklist. Can Fam Physician 1984;30:1527-1532.

11. Bliss C. El estilo de vida y el estándar de vida. En: Nussbaum MC, Sen A. La Calidad de Vida. México, D.F.: 1a. ed. Fondo de Cultura Económica, 1996: 534-557.

12. Walker SN, Sechrist KR, Pender NJ. The Health-Promoting Lifestyle Profile: Development and psychometric characteristics. Nurs Res 1987;36(2):76-81.

13. López-Carmona JM, Rodríguez-Moctezuma R, Munguía-Miranda C, Hernández-Santiago JL, Casas de la Torre E. Validez y fiabilidad del instrumento “FANTASTIC” para medir el estilo de vida en pacientes mexicanos con hipertensión arterial. Aten Primaria 2000;26(8):542-549.

14. Rodríguez-Moctezuma R, López-Carmona JM, Munguía-Miranda C, Hernández-Santiago JL, Martínez-Bermúdez M. Validez y consistencia del instrumento “FANTASTIC” para medir el estilo de vida en pacientes mexicanos con diabetes mellitus tipo 2. Rev Med IMSS 2003;41(3): 215-224.

15. Guyatt GH, Veldhuyzen-Van Zanten SJ, Feeny DH, Patrick DL. Measuring quality of life in clinical trials: A taxonomy and review. CMAJ 1989;140:1441-1448.

16. López JF, Rhode LE, Ponce de León RS. Medición del impacto de intervenciones médicas a nivel individual. Rev Invest Clin 1997;49: 379-386.

17. Anderson R, Fitzgerald J, Wisdom K, Davis W, Hiss R. A comparison of global versus disease-specific quality-of-life measures in patients with NIDDM. Diabetes Care 1997;20(3):299-305.

18. Feinstein AR. The evaluation of validity. En: Feinstein AR. Clinimetrics. New Haven (CT): Yale University Press, 1987.

19. Streiner DL, Norman GR. Health measurement scales. A practical guide to their development and use. 2da ed. Nueva York (NY): Oxford University Press, 1995.

20. Argimon-Pallás JM, Jiménez-Villa J. Métodos de investigación clínica y epidemiológica. 2da ed. Barcelona: Harcourt, 1999.

21. Prieto L, Badia X. Cuestionarios de salud: concepto y metodología. Aten Primaria 2001;28:201-209.

22. Wilson DM, Ciliska D. Lifestyle assessment: Testing the FANTASTIC Instrument. Can Fam Physician 1984;30:1863-1866.

23. Walker SN, Kerr MJ, Pender NJ, Sechrist KR. A Spanish language version of the Health- Promoting Lifestyle Profile. Nurs Res 1990;39(5): 268-273.

24. Hair JF, Anderson RE, Tatham RL, Black WC. Análisis multivariante. 5a ed. Madrid: Prentice Hall, 1999.

25. Kuster AE, Fong CM. Further psychometric evaluation of the Spanish language Health-Promoting Lifestyle Profile. Nurs Res 1993;42(5): 266-269.

26. Huang YH, Chiou CJ. Assessment of the Health-Promoting Lifestyle Profile on reliability and validity. Kaonsiung J Med Sci 1996;12(9): 529-537.

27. Walker SN, Volkan K, Sechrist KR, Pender NJ. Health promoting lifestyles of older adults: comparisons with young and middle-aged adults, correlates and patterns. ANS Adv Nurs Sci 1988;11(1):76-90.